InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,075.38
(
0.10%
)
US TECH 100
17,065.20
(
0.37%
)
Dow Jones
38,499.85
(
-0.01%
)
Brent Oil
87.31
(
-0.30%
)
Bitcoin
64,216.17
(
-3.30%
)
Post# of 10776
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

StockHighAlert-

Send PM Follow Ignore
Followers 129
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

StockHighAlert-

Re: None

Friday, 03/22/2019 1:12:29 PM

Friday, March 22, 2019 1:12:29 PM

Post# of 10776
Q BioMed’s Diagnostic Kit Designed to Serve Unmet Need for 70 Million Glaucoma Sufferers
Q BioMed Inc. (OTC – QBIO - $2.052 - NR) and its key technology partners are set to initiate development of an industry-changing diagnostic kit for monitoring glaucoma severity and progression. Pending FDA clearance, which could come sooner than many biotech investors might expect, this kit offers the potential to improve the quality of life for glaucoma sufferers by helping preserve visual function in glaucoma patients through accurate monitoring of disease progression. As a result, this diagnostic offers substantial future value to the Company. https://www.goldmanresearch.com/201903201237/Opportunity-Research/qbio-to-develop-revolutionary-product-for-glaucoma-market.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up